The case is In Re Gardasil Products Liability Litigation, 3:22-MD-03036-KDB, US District Court for the Western District of ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually prevents cancer. That’s because HPV is behind nearly all cervical cancer cases ...

In the fourth quarter of 2024, worldwide sales of Gardasil products fell 17% to $1.6 billion, while for the full year they fell 3% to $7.6 billion. MSD has attributed the fall to lower demand in ...

(Bloomberg) -- Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ... distribution partner Chongqing Zhifei ...

Picture this: It’s circa 2012 and I’m 13 years old, sitting awkwardly in my doctor’s office for my yearly physical, learning about the HPV vaccine. My doctor has just explained that the ...

Merck has a strong vaccine business, thanks to the human papillomavirus (HPV) products Gardasil and Gardasil 9. It's also a leader in the animal health business. However, its shares underperformed the ...

And ever since Gardasil gained US Food and Drug Administration (FDA) approval last June, Merck has made no secret of its ambition to make it into a blockbuster product. In 2005, 1,500 of its sales ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

(Reuters) -A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and ...

Gardasil and Gardasil 9 are together Merck's second best-selling product, with global sales of $8.58 billion in 2024. U.S. patent protection expires in 2028. The U.S. Centers for Disease Control ...